Grace Anne Dorney Koppel was told she only had a few years left after her 2001 COPD diagnosis. Now, the couple provides the ...

New data to be shared on GSK’s RSV vaccine across different age groups of patients at increased risk • Efficacy data for gepotidacin in ...

Shed Seven successfully earn their second Number 1 album in a year with Liquid Gold. Following up their first-ever chart-topper A Matter of Time back in January, it’s only taken the York ...

Among watch cognoscenti, Trump’s solid-gold timepiece attracted instant opprobrium. Industry experts said that it likely cost between $20,000 and $30,000 to make each watch. A tourbillon is an ...

Use the live African Gold Ltd share price chart to monitor the movements of the stock in real-time. Assess key data such as the daily change, high and low prices. A handy A1G trading volume graph is ...

Ohtuvayre is the first novel inhaled mechanism for the maintenance treatment of COPD in more than 20 years. The analyses will summarize the efficacy and safety of Ohtuvayre in subgroups of COPD ...

Gum disease is a common issue for many adults, possibly causing red or bleeding gums. Treatment may involve cleaning bacteria from under the gums and maintaining good dental hygiene at home.

Dupixent is now cleared for use as an add-on maintenance treatment for adults with a certain kind of chronic obstructive pulmonary disease, or COPD, that can’t be controlled with other medications.

The health regulator has cleared the drug's use as an add-on treatment for some adults with inadequately controlled chronic obstructive pulmonary disease (COPD), a condition that progressively ...

With the label expansion, Dupixent becomes the first biologic treatment for COPD patients in the U.S. The IL-4 and IL-13 inhibitor is approved to be used as an add-on maintenance treatment by ...

Dupixent for the treatment of COPD has been approved in more than 30 countries across the world, including the 27 countries in the European Union. Sanofi NewsMORE Related Stocks Indices ...